The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study
- 1 April 2002
- Vol. 57 (4) , 297-305
- https://doi.org/10.1034/j.1398-9995.2002.1o3532.x
Abstract
Background: There is only very limited documentation of the efficacy and safety of high‐dose subcutaneous birch pollen immunotherapy (IT) in double‐blind, placebo‐controlled (DBPC) studies. Birch po...Keywords
This publication has 31 references indexed in Scilit:
- Grass pollen immunotherapy for seasonal rhinitis and asthma: A randomized, controlled trialJournal of Allergy and Clinical Immunology, 2001
- Allergen‐specific immunotherapy in birch‐ and grass‐pollen‐allergic rhinitis. I. Efficacy estimated by a model reducing the biasof annual differences in pollen countsAllergy, 2000
- Quality of life in allergic rhinitisAnnals of Allergy, Asthma & Immunology, 1999
- Tree‐pollen allergy is efficiently treated by short‐term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergensAllergy, 1998
- Allergic rhinitis to ragweed pollen: I. Reassessment of the effects of immunotherapy on cellular and humoral responsesJournal of Allergy and Clinical Immunology, 1992
- Evaluation of immunotherapy-induced changes in specific IgE, IgG and IgG subclasses in birch pollen allergic patients by means of immunoblotting.Allergy, 1990
- Immunotherapy with partially purified and standardized tree pollen extractsAllergy, 1988
- Immunotherapy with partially purified and standardized tree pollen extractsAllergy, 1988
- Diagnosis and immunotherapy of mould allergyAllergy, 1987
- Sensitive Glass Microfibre‐Based Histamine Analysis for Allergy Testing in Washed Blood CellsAllergy, 1985